Pubblicazioni

Role of intraperitoneal chemotherapy in ovarian cancer in the platinum-taxane-based era: a meta-analysis

2019 - CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Marchetti, C.; De Felice, F.; Perniola, G.; Palaia, I.; Musella, A.; Di Donato, V.; Cascialli, G.; Muzii, L.; Tombolini, V.; Benedetti Panici, P.

Are we ready for a paradigm shift from high-dose conventional to moderate hypofractionated radiotherapy in intermediate-high risk prostate cancer? A systematic review of randomized controlled trials with trial sequential analysis

2019 - CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Ferella, L.; Limoncin, E.; Vittorini, F.; Chalaszczyk, A.; Sorce, C.; Grimaldi, G.; Franzese, P.; Ruggieri, V.; Varrassi, E.; Di Staso, M.; Gimenez De Lorenzo, R.; Marampon, F.; Tombolini, V.; Masciocchi, C.; Gravina, G. L.

The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper

2019 - CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Cristofanilli, M.; Pierga, J. -Y.; Reuben, J.; Rademaker, A.; Davis, A. A.; Peeters, D. J.; Fehm, T.; Nole, F.; Gisbert-Criado, R.; Mavroudis, D.; Grisanti, S.; Giuliano, M.; Garcia-Saenz, J. A.; Stebbing, J.; Caldas, C.; Gazzaniga, P.; Manso, L.; Zamarchi, R.; de Lascoiti, A. F.; De Mattos-Arruda, L.; Ignatiadis, M.; Cabel, L.; van Laere, S. J.; Meier-Stiegen, F.; Sandri, M. -T.; Vidal-Martinez, J.; Politaki, E.; Consoli, F.; Generali, D.; Cappelletti, M. R.; Diaz-Rubio, E.; Krell, J.; Dawson, S. -J.; Raimondi, C.; Rutten, A.; Janni, W.; Munzone, E.; Caranana, V.; Agelaki, S.; Almici, C.; Dirix, L.; Solomayer, E. -F.; Zorzino, L.; Darrigues, L.; Reis-Filho, J. S.; Gerratana, L.; Michiels, S.; Bidard, F. -C.; Pantel, K.